Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 132

1.

Reproducibility and repeatability of semi-quantitative 18F-fluorodihydrotestosterone (FDHT) uptake metrics in castration-resistant prostate cancer metastases: a prospective multi-center study.

Vargas HA, Kramer GM, Scott AM, Weickhardt A, Meier AA, Parada N, Beattie BJ, Humm JL, Staton KD, Zanzonico PB, Lyashchenko SK, Lewis JS, Yaqub M, Sosa RE, van den Eertwegh AJ, Davis ID, Ackermann U, Pathmaraj K, Schuit RC, Windhorst AD, Chua S, Weber WA, Larson SM, Scher HI, Lammertsma AA, Hoekstra O, Morris MJ.

J Nucl Med. 2018 Apr 6. pii: jnumed.117.206490. doi: 10.2967/jnumed.117.206490. [Epub ahead of print]

PMID:
29626121
2.

Design, Synthesis and Evaluation of Branched RRWQWR-Based Peptides as Antibacterial Agents Against Clinically Relevant Gram-Positive and Gram-Negative Pathogens.

Vega SC, Martínez DA, Chalá MDS, Vargas HA, Rosas JE.

Front Microbiol. 2018 Mar 2;9:329. doi: 10.3389/fmicb.2018.00329. eCollection 2018.

3.

CT Features of Ovarian Tumors: Defining Key Differences Between Serous Borderline Tumors and Low-Grade Serous Carcinomas.

Nougaret S, Lakhman Y, Molinari N, Feier D, Scelzo C, Vargas HA, Sosa RE, Hricak H, Soslow RA, Grisham RN, Sala E.

AJR Am J Roentgenol. 2018 Apr;210(4):918-926. doi: 10.2214/AJR.17.18254. Epub 2018 Feb 28.

PMID:
29489407
4.

Genetic divergence of isolated populations of the native micromoth Bucculatrix mirnae (Lepidoptera: Bucculatricidae) in the arid environments of Northern Chile.

Vargas-Ortiz M, Bobadilla D, Huanca-Mamani W, Vargas HA.

Mitochondrial DNA A DNA Mapp Seq Anal. 2017 Dec 22:1-9. doi: 10.1080/24701394.2017.1419215. [Epub ahead of print]

PMID:
29272986
5.

Prostate cancer in 2017: Advances in imaging.

Wibmer AG, Vargas HA, Hricak H.

Nat Rev Urol. 2018 Feb;15(2):81-82. doi: 10.1038/nrurol.2017.210. Epub 2017 Dec 12. No abstract available.

PMID:
29231198
6.

Erratum to: Fertility-sparing for young patients with gynecologic cancer: How MRI can guide patient selection prior to conservative management.

McEvoy SH, Nougaret S, Abu-Rustum NR, Vargas HA, Sadowski EA, Menias CO, Shitano F, Fujii S, Sosa RE, Escalon JG, Sala E, Lakhman Y.

Abdom Radiol (NY). 2017 Dec;42(12):2966-2973. doi: 10.1007/s00261-017-1205-5.

PMID:
29128990
7.

Positron Emission Tomography/Computed Tomography-Based Assessments of Androgen Receptor Expression and Glycolytic Activity as a Prognostic Biomarker for Metastatic Castration-Resistant Prostate Cancer.

Fox JJ, Gavane SC, Blanc-Autran E, Nehmeh S, Gönen M, Beattie B, Vargas HA, Schöder H, Humm JL, Fine SW, Lewis JS, Solomon SB, Osborne JR, Veach D, Sawyers CL, Weber WA, Scher HI, Morris MJ, Larson SM.

JAMA Oncol. 2018 Feb 1;4(2):217-224. doi: 10.1001/jamaoncol.2017.3588.

PMID:
29121144
8.

Drug development for noncastrate prostate cancer in a changed therapeutic landscape.

Teo MY, O'Shaughnessy MJ, McBride SM, Vargas HA, Scher HI.

Nat Rev Clin Oncol. 2018 Mar;15(3):150. doi: 10.1038/nrclinonc.2017.177. Epub 2017 Nov 8.

PMID:
29115302
9.

Drug development for noncastrate prostate cancer in a changed therapeutic landscape.

Teo MY, O'Shaughnessy MJ, McBride SM, Vargas HA, Scher HI.

Nat Rev Clin Oncol. 2018 Mar;15(3):168-182. doi: 10.1038/nrclinonc.2017.160. Epub 2017 Oct 17. Review. Erratum in: Nat Rev Clin Oncol. 2017 Nov 08;:.

PMID:
29039422
10.

Heterogeneous Tumor-Immune Microenvironments among Differentially Growing Metastases in an Ovarian Cancer Patient.

Jiménez-Sánchez A, Memon D, Pourpe S, Veeraraghavan H, Li Y, Vargas HA, Gill MB, Park KJ, Zivanovic O, Konner J, Ricca J, Zamarin D, Walther T, Aghajanian C, Wolchok JD, Sala E, Merghoub T, Snyder A, Miller ML.

Cell. 2017 Aug 24;170(5):927-938.e20. doi: 10.1016/j.cell.2017.07.025.

11.

Prospective Genomic Profiling of Prostate Cancer Across Disease States Reveals Germline and Somatic Alterations That May Affect Clinical Decision Making.

Abida W, Armenia J, Gopalan A, Brennan R, Walsh M, Barron D, Danila D, Rathkopf D, Morris M, Slovin S, McLaughlin B, Curtis K, Hyman DM, Durack JC, Solomon SB, Arcila ME, Zehir A, Syed A, Gao J, Chakravarty D, Vargas HA, Robson ME, Joseph V, Offit K, Donoghue MTA, Abeshouse AA, Kundra R, Heins ZJ, Penson AV, Harris C, Taylor BS, Ladanyi M, Mandelker D, Zhang L, Reuter VE, Kantoff PW, Solit DB, Berger MF, Sawyers CL, Schultz N, Scher HI.

JCO Precis Oncol. 2017 Jul;2017. doi: 10.1200/PO.17.00029. Epub 2017 May 31.

PMID:
28825054
12.

Phenotypic Heterogeneity of Circulating Tumor Cells Informs Clinical Decisions between AR Signaling Inhibitors and Taxanes in Metastatic Prostate Cancer.

Scher HI, Graf RP, Schreiber NA, McLaughlin B, Jendrisak A, Wang Y, Lee J, Greene S, Krupa R, Lu D, Bamford P, Louw JE, Dugan L, Vargas HA, Fleisher M, Landers M, Heller G, Dittamore R.

Cancer Res. 2017 Oct 15;77(20):5687-5698. doi: 10.1158/0008-5472.CAN-17-1353. Epub 2017 Aug 17.

PMID:
28819021
13.

Rationale for Modernising Imaging in Advanced Prostate Cancer.

Padhani AR, Lecouvet FE, Tunariu N, Koh DM, De Keyzer F, Collins DJ, Sala E, Fanti S, Vargas HA, Petralia G, Schlemmer HP, Tombal B, de Bono J.

Eur Urol Focus. 2017 Apr;3(2-3):223-239. doi: 10.1016/j.euf.2016.06.018. Epub 2016 Jul 15. Review.

14.

From Staging to Prognostication: Achievements and Challenges of MR Imaging in the Assessment of Endometrial Cancer.

Nougaret S, Lakhman Y, Vargas HA, Colombo PE, Fujii S, Reinhold C, Sala E.

Magn Reson Imaging Clin N Am. 2017 Aug;25(3):611-633. doi: 10.1016/j.mric.2017.03.010. Epub 2017 May 27. Review.

PMID:
28668163
15.

Radiogenomics of High-Grade Serous Ovarian Cancer: Multireader Multi-Institutional Study from the Cancer Genome Atlas Ovarian Cancer Imaging Research Group.

Vargas HA, Huang EP, Lakhman Y, Ippolito JE, Bhosale P, Mellnick V, Shinagare AB, Anello M, Kirby J, Fevrier-Sullivan B, Freymann J, Jaffe CC, Sala E.

Radiology. 2017 Nov;285(2):482-492. doi: 10.1148/radiol.2017161870. Epub 2017 Jun 22.

PMID:
28641043
16.

Causes of Avascular Hypoechoic Testicular Lesions Detected at Scrotal Ultrasound: Can They Be Considered Benign?

Ma W, Sarasohn D, Zheng J, Vargas HA, Bach A.

AJR Am J Roentgenol. 2017 Jul;209(1):110-115. doi: 10.2214/AJR.16.17333.

PMID:
28639925
17.

High-Grade Serous Ovarian Cancer: Associations between BRCA Mutation Status, CT Imaging Phenotypes, and Clinical Outcomes.

Nougaret S, Lakhman Y, Gönen M, Goldman DA, Miccò M, D'Anastasi M, Johnson SA, Juluru K, Arnold AG, Sosa RE, Soslow RA, Vargas HA, Hricak H, Kauff ND, Sala E.

Radiology. 2017 Nov;285(2):472-481. doi: 10.1148/radiol.2017161697. Epub 2017 Jun 16.

PMID:
28628421
18.

Fertility-sparing for young patients with gynecologic cancer: How MRI can guide patient selection prior to conservative management.

McEvoy SH, Nougaret S, Abu-Rustum NR, Vargas HA, Sadowski EA, Menias CO, Shitano F, Fujii S, Sosa RE, Escalon JG, Sala E, Lakhman Y.

Abdom Radiol (NY). 2017 Oct;42(10):2488-2512. doi: 10.1007/s00261-017-1179-3. Review. Erratum in: Abdom Radiol (NY). 2017 Nov 11;:.

PMID:
28528388
19.

Lioptilodes friasi (Lepidoptera: Pterophoridae) Niche Breadth in the Chilean Mediterranean Matorral Biome: Trophic and Altitudinal Dimensions.

Vargas HA, Rasmann S, Ramirez-Verdugo P, Villagra CA.

Neotrop Entomol. 2018 Feb;47(1):62-68. doi: 10.1007/s13744-017-0514-2. Epub 2017 Apr 6.

PMID:
28386773
20.

Detection of Clinically Significant Prostate Cancer: Short Dual-Pulse Sequence versus Standard Multiparametric MR Imaging-A Multireader Study.

Barth BK, De Visschere PJL, Cornelius A, Nicolau C, Vargas HA, Eberli D, Donati OF.

Radiology. 2017 Sep;284(3):725-736. doi: 10.1148/radiol.2017162020. Epub 2017 Mar 27.

PMID:
28346073
21.

A novel representation of inter-site tumour heterogeneity from pre-treatment computed tomography textures classifies ovarian cancers by clinical outcome.

Vargas HA, Veeraraghavan H, Micco M, Nougaret S, Lakhman Y, Meier AA, Sosa R, Soslow RA, Levine DA, Weigelt B, Aghajanian C, Hricak H, Deasy J, Snyder A, Sala E.

Eur Radiol. 2017 Sep;27(9):3991-4001. doi: 10.1007/s00330-017-4779-y. Epub 2017 Mar 13.

PMID:
28289945
22.

Author Reply.

O'Shaughnessy MJ, McBride SM, Vargas HA, Scher HI.

Urology. 2017 Apr;102:172. doi: 10.1016/j.urology.2016.10.046. Epub 2017 Mar 6. No abstract available.

PMID:
28279479
23.

The performance of PI-RADSv2 and quantitative apparent diffusion coefficient for predicting confirmatory prostate biopsy findings in patients considered for active surveillance of prostate cancer.

Nougaret S, Robertson N, Golia Pernicka J, Molinari N, Hötker AM, Ehdaie B, Sala E, Hricak H, Vargas HA.

Abdom Radiol (NY). 2017 Jul;42(7):1968-1974. doi: 10.1007/s00261-017-1086-7.

PMID:
28258355
24.

Combined Whole Body and Multiparametric Prostate Magnetic Resonance Imaging as a 1-Step Approach to the Simultaneous Assessment of Local Recurrence and Metastatic Disease after Radical Prostatectomy.

Robertson NL, Sala E, Benz M, Landa J, Scardino P, Scher HI, Hricak H, Vargas HA.

J Urol. 2017 Jul;198(1):65-70. doi: 10.1016/j.juro.2017.02.071. Epub 2017 Feb 16.

PMID:
28216327
25.

Validation of 3D volumetric-based renal function prediction calculator for nephron sparing surgery.

Corradi R, Kabra A, Suarez M, Oppenheimer J, Okhunov Z, White H, Nougaret S, Vargas HA, Landman J, Coleman J, Liss MA.

Int Urol Nephrol. 2017 Apr;49(4):615-621. doi: 10.1007/s11255-017-1525-y. Epub 2017 Feb 4.

26.

Renal Masses Detected on FDG PET/CT in Patients With Lymphoma: Imaging Features Differentiating Primary Renal Cell Carcinomas From Renal Lymphomatous Involvement.

Nicolau C, Sala E, Kumar A, Goldman DA, Schoder H, Hricak H, Vargas HA.

AJR Am J Roentgenol. 2017 Apr;208(4):849-853. doi: 10.2214/AJR.16.17133. Epub 2017 Jan 17.

27.

Abdominal wall endometriosis: differentiation from other masses using CT features.

Yarmish G, Sala E, Goldman DA, Lakhman Y, Soslow RA, Hricak H, Gardner GJ, Vargas HA.

Abdom Radiol (NY). 2017 May;42(5):1517-1523. doi: 10.1007/s00261-016-0998-y.

PMID:
28004137
28.

Differentiation of Uterine Leiomyosarcoma from Atypical Leiomyoma: Diagnostic Accuracy of Qualitative MR Imaging Features and Feasibility of Texture Analysis.

Lakhman Y, Veeraraghavan H, Chaim J, Feier D, Goldman DA, Moskowitz CS, Nougaret S, Sosa RE, Vargas HA, Soslow RA, Abu-Rustum NR, Hricak H, Sala E.

Eur Radiol. 2017 Jul;27(7):2903-2915. doi: 10.1007/s00330-016-4623-9. Epub 2016 Dec 5.

PMID:
27921159
29.

A Pilot Study of a Multimodal Treatment Paradigm to Accelerate Drug Evaluations in Early-stage Metastatic Prostate Cancer.

O'Shaughnessy MJ, McBride SM, Vargas HA, Touijer KA, Morris MJ, Danila DC, Laudone VP, Bochner BH, Sheinfeld J, Dayan ES, Bellomo LP, Sjoberg DD, Heller G, Zelefsky MJ, Eastham JA, Scardino PT, Scher HI.

Urology. 2017 Apr;102:164-172. doi: 10.1016/j.urology.2016.10.044. Epub 2016 Nov 22.

30.

Unravelling tumour heterogeneity using next-generation imaging: radiomics, radiogenomics, and habitat imaging.

Sala E, Mema E, Himoto Y, Veeraraghavan H, Brenton JD, Snyder A, Weigelt B, Vargas HA.

Clin Radiol. 2017 Jan;72(1):3-10. doi: 10.1016/j.crad.2016.09.013. Epub 2016 Oct 11. Review.

31.

Prostate magnetic resonance imaging findings in patients treated for testosterone deficiency while on active surveillance for low-risk prostate cancer.

Hashimoto T, Rahul K, Takeda T, Benfante N, Mulhall JP, Hricak H, Eastham JA, Vargas HA.

Urol Oncol. 2016 Dec;34(12):530.e9-530.e14. doi: 10.1016/j.urolonc.2016.07.004. Epub 2016 Sep 22.

32.

Pharmacological treatment and impairment of pulmonary function in patients with type 2 diabetes: a cross-sectional study.

Vargas HA, Rondón M, Dennis R.

Biomedica. 2016 Jun 3;36(2):276-84. doi: 10.7705/biomedica.v36i3.2752.

PMID:
27622489
33.

Patterns of Lymph Node Failure after Dose-escalated Radiotherapy: Implications for Extended Pelvic Lymph Node Coverage.

Spratt DE, Vargas HA, Zumsteg ZS, Golia Pernicka JS, Osborne JR, Pei X, Zelefsky MJ.

Eur Urol. 2017 Jan;71(1):37-43. doi: 10.1016/j.eururo.2016.07.043. Epub 2016 Aug 11.

34.

Prostate cancer bone metastases on staging prostate MRI: prevalence and clinical features associated with their diagnosis.

Vargas HA, Schor-Bardach R, Long N, Kirzner AN, Cunningham JD, Goldman DA, Moskowitz CS, Sosa RE, Sala E, Panicek DM, Hricak H.

Abdom Radiol (NY). 2017 Jan;42(1):271-277. doi: 10.1007/s00261-016-0851-3.

35.

Localizing sites of disease in patients with rising serum prostate-specific antigen up to 1ng/ml following prostatectomy: How much information can conventional imaging provide?

Vargas HA, Martin-Malburet AG, Takeda T, Corradi RB, Eastham J, Wibmer A, Sala E, Zelefsky MJ, Weber WA, Hricak H.

Urol Oncol. 2016 Nov;34(11):482.e5-482.e10. doi: 10.1016/j.urolonc.2016.05.026. Epub 2016 Jun 23.

36.

METastasis Reporting and Data System for Prostate Cancer: Practical Guidelines for Acquisition, Interpretation, and Reporting of Whole-body Magnetic Resonance Imaging-based Evaluations of Multiorgan Involvement in Advanced Prostate Cancer.

Padhani AR, Lecouvet FE, Tunariu N, Koh DM, De Keyzer F, Collins DJ, Sala E, Schlemmer HP, Petralia G, Vargas HA, Fanti S, Tombal HB, de Bono J.

Eur Urol. 2017 Jan;71(1):81-92. doi: 10.1016/j.eururo.2016.05.033. Epub 2016 Jun 14.

37.

Association of AR-V7 on Circulating Tumor Cells as a Treatment-Specific Biomarker With Outcomes and Survival in Castration-Resistant Prostate Cancer.

Scher HI, Lu D, Schreiber NA, Louw J, Graf RP, Vargas HA, Johnson A, Jendrisak A, Bambury R, Danila D, McLaughlin B, Wahl J, Greene SB, Heller G, Marrinucci D, Fleisher M, Dittamore R.

JAMA Oncol. 2016 Nov 1;2(11):1441-1449. doi: 10.1001/jamaoncol.2016.1828. Erratum in: JAMA Oncol. 2016 Nov 1;2(11):1511.

38.

Role of MRI in the Risk Assessment of Primary Prostate Cancer.

Wibmer A, Verma S, Vargas HA.

Top Magn Reson Imaging. 2016 Jun;25(3):133-8. doi: 10.1097/RMR.0000000000000081. Review.

PMID:
27187162
39.

Comparative Effectiveness of Targeted Prostate Biopsy Using Magnetic Resonance Imaging Ultrasound Fusion Software and Visual Targeting: a Prospective Study.

Lee DJ, Recabal P, Sjoberg DD, Thong A, Lee JK, Eastham JA, Scardino PT, Vargas HA, Coleman J, Ehdaie B.

J Urol. 2016 Sep;196(3):697-702. doi: 10.1016/j.juro.2016.03.149. Epub 2016 Mar 30.

40.

Long-term outcome of magnetic resonance spectroscopic image-directed dose escalation for prostate brachytherapy.

King MT, Nasser NJ, Mathur N, Cohen GN, Kollmeier MA, Yuen J, Vargas HA, Pei X, Yamada Y, Zakian KL, Zaider M, Zelefsky MJ.

Brachytherapy. 2016 May-Jun;15(3):266-73. doi: 10.1016/j.brachy.2016.02.003. Epub 2016 Apr 20.

41.

The Efficacy of Multiparametric Magnetic Resonance Imaging and Magnetic Resonance Imaging Targeted Biopsy in Risk Classification for Patients with Prostate Cancer on Active Surveillance.

Recabal P, Assel M, Sjoberg DD, Lee D, Laudone VP, Touijer K, Eastham JA, Vargas HA, Coleman J, Ehdaie B.

J Urol. 2016 Aug;196(2):374-81. doi: 10.1016/j.juro.2016.02.084. Epub 2016 Feb 23.

42.

Intravoxel Incoherent Motion-derived Histogram Metrics for Assessment of Response after Combined Chemotherapy and Radiation Therapy in Rectal Cancer: Initial Experience and Comparison between Single-Section and Volumetric Analyses.

Nougaret S, Vargas HA, Lakhman Y, Sudre R, Do RK, Bibeau F, Azria D, Assenat E, Molinari N, Pierredon MA, Rouanet P, Guiu B.

Radiology. 2016 Aug;280(2):446-54. doi: 10.1148/radiol.2016150702. Epub 2016 Feb 26.

43.

The expanding landscape of diffusion-weighted MRI in prostate cancer.

Wibmer AG, Sala E, Hricak H, Vargas HA.

Abdom Radiol (NY). 2016 May;41(5):854-61. doi: 10.1007/s00261-016-0646-6. Review.

44.

The impact of FDG-PET/CT in the management of patients with vulvar and vaginal cancer.

Robertson NL, Hricak H, Sonoda Y, Sosa RE, Benz M, Lyons G, Abu-Rustum NR, Sala E, Vargas HA.

Gynecol Oncol. 2016 Mar;140(3):420-4. doi: 10.1016/j.ygyno.2016.01.011. Epub 2016 Jan 11.

45.

Functional MR Imaging Techniques in Oncology in the Era of Personalized Medicine.

Benz MR, Vargas HA, Sala E.

Magn Reson Imaging Clin N Am. 2016 Feb;24(1):1-10. doi: 10.1016/j.mric.2015.08.001. Epub 2015 Sep 26. Review.

46.

Imaging Features of Uncommon Gynecologic Cancers.

Miccò M, Sala E, Lakhman Y, Hricak H, Vargas HA.

AJR Am J Roentgenol. 2015 Dec;205(6):1346-59. doi: 10.2214/AJR.14.12695. Review.

47.

Molecular Imaging of Prostate Cancer.

Wibmer AG, Burger IA, Sala E, Hricak H, Weber WA, Vargas HA.

Radiographics. 2016 Jan-Feb;36(1):142-59. doi: 10.1148/rg.2016150059. Epub 2015 Nov 20. Review.

48.

Automatic classification of prostate cancer Gleason scores from multiparametric magnetic resonance images.

Fehr D, Veeraraghavan H, Wibmer A, Gondo T, Matsumoto K, Vargas HA, Sala E, Hricak H, Deasy JO.

Proc Natl Acad Sci U S A. 2015 Nov 17;112(46):E6265-73. doi: 10.1073/pnas.1505935112. Epub 2015 Nov 2.

49.

Low yield of surveillance imaging after surgery for T1 kidney cancer.

Feuerstein MA, Musser JE, Kent M, Chevinsky M, Cha EK, Kimm S, Hilton WM, Sjoberg DD, Donahue TF, Vargas HA, Coleman JA, Russo P.

World J Urol. 2016 Jul;34(7):949-53. doi: 10.1007/s00345-015-1719-9. Epub 2015 Oct 28.

50.

Second-Opinion Interpretations of Gynecologic Oncologic MRI Examinations by Sub-Specialized Radiologists Influence Patient Care.

Lakhman Y, D'Anastasi M, Miccò M, Scelzo C, Vargas HA, Nougaret S, Sosa RE, Chi DS, Abu-Rustum NR, Hricak H, Sala E.

Eur Radiol. 2016 Jul;26(7):2089-98. doi: 10.1007/s00330-015-4040-5. Epub 2015 Oct 22.

Supplemental Content

Loading ...
Support Center